Can-Fite BioPharma Ltd Forecast and Stock Analysis
Technical CANF stock analysis for March 25, 2019.
|Shorts||1.62% ( 2019-02-28 )|
Can-Fite BioPharma Ltd gained 4.03% in the last trading day, rising from $1.24 to $1.29 The price has risen in 6 of the last 10 days and is up by 18.35% over the past 2 weeks. Volume fell in the last day by -7 923 shares, and in total, 241 399 shares bought and sold for approximately $311 405.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the CANF stock was $1.29. This is 4.03% more than the trading day before Friday, 22nd Mar 2019.
During day the stock fluctuated 6.50% from a day low at $1.23 to a day high of $1.31.
30 day high of the CANF stock price was $1.62 and low was $1.05.
90 day high was $1.62 and low was $1.00.
52 week high for the Can-Fite BioPharma Ltd - $1.73 and low - $1.00.
Can-Fite BioPharma Ltd lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.05% during the next 3 months and, with 90% probability hold a price between $1.06 and $1.32 at the end of this period.
Can-Fite BioPharma Ltd holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.25 and $1.17. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday March 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 66 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $1.20 and $1.19.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Can-Fite BioPharma Ltd finds support just below today's level at $1.20. If this is broken, then the next support from accumulated volume will be at $1.19 and $1.17.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 6.50%. For the last week the stock has had a daily average volatility of 16.77%.
Our recommended stoploss: $1.23 (-4.43%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.